REATA PHARMACEUTICALS INC: 10-Q filed 2016-11-14
What REATA PHARMACEUTICALS INC reported in its quarterly report filed 2016-11-14 (fiscal Q3 2016): 27 published measures, 80 facts as tagged in accession 0001564590-16-029087.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2016-11-14
- Fiscal period
- fiscal Q3 2016
- Accession
- 0001564590-16-029087 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All REATA PHARMACEUTICALS INC filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 101,823,000 | USD | |
| At 2015-12-31 | 78,954,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | -212,289,000 | USD | |
| At 2015-12-31 | -273,156,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 95,660,000 | USD | |
| At 2015-12-31 | 42,008,000 | USD | |
| At 2015-09-30 | 55,051,000 | USD | |
| At 2014-12-31 | 87,758,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -897,000 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -2,091,000 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 633,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 296,000 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-09-30 | 281,000 | USD | 274 |
| 2015-01-01 to 2015-09-30 | 257,000 | USD | 273 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 12,551,000 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 37,355,000 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 12,500,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 37,794,000 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | -285,218,000 | USD | |
| At 2015-12-31 | -283,127,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 22,324,374 | shares | 92 |
| 2016-01-01 to 2016-09-30 | 18,970,128 | shares | 274 |
| 2015-07-01 to 2015-09-30 | 15,979,614 | shares | 92 |
| 2015-01-01 to 2015-09-30 | 15,974,510 | shares | 273 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 22,324,374 | shares | 92 |
| 2016-01-01 to 2016-09-30 | 18,970,128 | shares | 274 |
| 2015-07-01 to 2015-09-30 | 16,149,149 | shares | 92 |
| 2015-01-01 to 2015-09-30 | 16,082,963 | shares | 273 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -0.04 | USD/shares | 92 |
| 2016-01-01 to 2016-09-30 | -0.11 | USD/shares | 274 |
| 2015-07-01 to 2015-09-30 | 0.04 | USD/shares | 92 |
| 2015-01-01 to 2015-09-30 | 0.02 | USD/shares | 273 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -0.04 | USD/shares | 92 |
| 2016-01-01 to 2016-09-30 | -0.11 | USD/shares | 274 |
| 2015-07-01 to 2015-09-30 | 0.04 | USD/shares | 92 |
| 2015-01-01 to 2015-09-30 | 0.02 | USD/shares | 273 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 1,000 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -442,000 | USD | 274 |
| 2015-07-01 to 2015-09-30 | -140,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -44,000 | USD | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 899,000 | USD | |
| At 2015-12-31 | 1,142,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-09-30 | 1,451,000 | USD | 274 |
| 2015-01-01 to 2015-09-30 | 1,019,000 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 99,920,000 | USD | |
| At 2015-12-31 | 77,259,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 60,071,000 | USD | |
| At 2015-12-31 | 60,820,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 1,296,000 | USD | |
| At 2015-12-31 | 3,531,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 13,509,000 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 40,001,000 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 12,016,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 37,567,000 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 9,300,000 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 27,681,000 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 8,550,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 26,816,000 | USD | 273 |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 1,004,000 | USD | |
| At 2015-12-31 | 553,000 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 94,000 | USD | |
| At 2015-12-31 | 249,000 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 4,424,000 | USD | |
| At 2015-12-31 | 3,529,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-09-30 | 4,260,000 | USD | |
| At 2015-12-31 | 3,325,000 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | -896,000 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -2,533,000 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 493,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 252,000 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 4,039,000 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 11,783,000 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 2,980,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 9,203,000 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-07-01 to 2016-09-30 | 62,000 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 113,000 | USD | 274 |
| 2015-07-01 to 2015-09-30 | 9,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 25,000 | USD | 273 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-09-30 | -2,235,000 | USD | 274 |
| 2015-01-01 to 2015-09-30 | 665,000 | USD | 273 |
Inspect the source
- Entity
- REATA PHARMACEUTICALS INC / CIK 0001358762
- Captured
- SEC response SHA-256
8befebdc7b41f2a10ca7038692fc79bddef3d5fcc8d7bae754774b8cee416aa1
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001358762.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))